Delivery Order SPE2DB22D2006-SPE2DB24FW1XV

Award Date 7/15/24
Potential Completion Date 7/16/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,069.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of HUMALOG 100 UNIT/ML KWIKPEN 3ML, a prescription insulin medication. The order has an ultimate completion date of August 21, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Humalog, a brand-name insulin product, with a ceiling value of $1,092.35 and a performance period ending on May 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Humalog insulin vials. The $1,639.44 firm-fixed-price contract has a completion date of May 22, 2024. The award is not designated as a set-aside contract, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The Defense Logistics Agency awarded a $546 delivery order to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml vials of Humalog insulin. The firm fixed price order is for 10 ml vials of the drug to be delivered to a facility in Conshohocken, Pennsylvania between September 18-19, 2023. Amerisourcebergen will fulfill the order as the prime contractor. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical supplies are...
This federal contract award, with ID SPE2DB22D3004|SPE2DB24FQL04, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,092.96 firm fixed-price delivery order is for the supply of Humalog 100 unit/mL insulin vials. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,379.35 firm fixed price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a diabetes medication. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,277.00 firm-fixed-price delivery order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML, a prescription medication. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation, is for the delivery of Humalog insulin vials to the U.S. government. The $1,110.99 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense (DoD). This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Humalog insulin vials, a critical diabetes medication, with a ceiling value of $1,639.44 and an ultimate completion date of July 26, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $1,956.03 order is for the supply of HUMALOG 100 UNIT/ML VIAL 10ML pharmaceuticals. This order is part of Amerisourcebergen's broader indefinite delivery contract with DLA to provide pharmaceuticals and medical supplies in support of military treatment programs and facilities. No set-aside...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1XV
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceuticals and medical supplies to DLA facilities supporting the Department of Defense worldwide. This latest delivery order is an individual task order under that larger IDC. The contract has no set-aside designation and was awarded on a full and open competition basis, reflecting Amerisourcebergen's competitive position in the federal pharmaceutical market.

Generated 10/14/24, 9:58 AM